OAK RIDGE INVESTMENTS LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1054554 Chicago, IL

Position in URGN

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$3,260,148

+$1,706,623 QoQ

Shares Held

88,591

+2.5% QoQ

Ownership

0.181%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#50

of 189 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

OAK RIDGE INVESTMENTS LLC holds $38,931,682 across 19 Biotechnology names. URGN ranks #3 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	14,619	$3,578,292
2	HALO	Halozyme Therapeutics, Inc.	43,515	$3,405,919
3	URGN	UroGen Pharma Ltd. This page	88,591	$3,260,148
4	CORT	Corcept Therapeutics Inc	34,172	$2,971,255
5	TVTX	Travere Therapeutics, Inc.	52,234	$2,967,413
6	BBIO	BridgeBio Pharma, Inc.	38,190	$2,844,391
7	CYTK	Cytokinetics Inc	32,518	$2,770,208
8	MIRM	Mirum Pharmaceuticals, Inc.	22,408	$2,623,304

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,260,148	88,591	+2.5%	Shares	Sole	2026-07-21
2026-03-31	$1,553,525	86,403	+1.4%	Shares	Sole	2026-04-30
2025-12-31	$1,996,086	85,230	-2.6%	Shares	Sole	2026-01-23
2025-09-30	$1,745,764	87,507	+24.0%	Shares	Sole	2025-10-29
2025-06-30	$966,809	70,570	-4.3%	Shares	Sole	2025-07-25
2025-03-31	$815,166	73,704	+20.5%	Shares	Sole	2025-05-13
2024-12-31	$651,407	61,165	-20.4%	Shares	Sole	2025-01-15
2024-09-30	$975,347	76,799	-3.9%	Shares	Sole	2024-10-28
2024-06-30	$1,341,208	79,929	+30.6%	Shares	Sole	2024-10-28
2024-03-31	$918,060	61,204	—	Shares	Sole	2024-05-01
No filing history on record for this holder in this stock.